Table 1.
Characteristics | ARROW | CHAPAS‐3 | Combined | |
---|---|---|---|---|
iPK | iPK | sPK | ||
No. of children * | 41 | 51 | 128 | 169 |
No. of samples | 611 | 474 | 1002 | 2087 |
Sampling schedule | 0 h, 1 h, 2 h, 4 h, 6 h, 8 h, 12 h, 24 h | 2 samples 2 h apart | ||
No. of samples excluded | 9 | 8 | 5 | 22 |
Age (years) ** | 7.6 (4.0–12.5) | 4.5 (2.1–13.8) | 4.7 (2.1–13.8) | |
Weight (kg) ** | 20.0 (14.0–30.0) | 15.0 (7.8–29.9) | 15.5 (7.8–30.0) | |
Sex (M/F) | 17/24 | 63/65 | 80/89 | |
Race | Black African | |||
CYP2B6 516GT (rs3745274; HWE P = 1) † | ||||
GG | 16 (44%) | 49 (39%) | 65 (40%) | |
GT | 14 (39%) | 53 (42%) | 67 (41%) | |
TT | 6 (17%) | 24 (19%) | 30 (19%) | |
MAF | 0.36 | 0.40 | 0.39 | |
CYP2B6 983T>C (rs28399499; HWE P = 0.6) † | ||||
TT | 33 (92%) | 106 (84%) | 139 (86%) | |
TC | 3 (8%) | 19 (15%) | 22 (14%) | |
CC | 0 (0%) | 1 (1%) | 1 (1%) | |
MAF | 0.04 | 0.08 | 0.07 | |
CYP2B6 15582C>T (rs4803419; HWE P = 1) † | ||||
CC | 32 (89%) | 113 (90%) | 145 (90%) | |
TC | 4 (11%) | 13 (10%) | 17 (10%) | |
MAF | 0.06 | 0.05 | 0.05 | |
CYP3A4*22 (rs35599367) † | ||||
GG | 36 (100%) | 126 (100%) | 162 (100%) | |
CYP3A5 6986G>A (rs776746; HWE P = 0.57) † | ||||
GG | 1 (3%) | 2 (2%) | 3 (2%) | |
GA | 7 (19%) | 41 (33%) | 48 (30%) | |
AA | 28 (78%) | 83 (66%) | 111 (69%) | |
MAF | 0.12 | 0.18 | 0.17 | |
NR1I3 (rs3003596; HWE P = 0.34) † | ||||
AA | 7 (19%) | 30 (24%) | 37 (23%) | |
AG | 18 (50%) | 55 (44%) | 73 (45%) | |
GG | 11 (31%) | 41 (33%) | 52 (32%) | |
MAF | 0.46 | 0.46 | 0.46 | |
NR1I3 540 C>T (rs2307424; HWE P = 1) † | ||||
TT | 0 | 1 (1%) | 1 (1%) | |
CT | 3 (8%) | 23 (18%) | 26 (16%) | |
CC | 33 (92%) | 102 (81%) | 135 (83%) | |
MAF | 0.04 | 0.10 | 0.09 | |
NR1I2 63396C>T (rs2472677; HWE P = 0.07) † | ||||
CC | 13 (36%) | 43 (34%) | 56 (35%) | |
CT | 16 (44%) | 72 (57%) | 88 (54%) | |
TT | 7 (19%) | 11 (9%) | 18 (11%) | |
MAF | 0.42 | 0.37 | 0.38 | |
CYP2B6*4 785A>G (rs2279343; HWE P = 0.47) ‡ | ||||
AA | 16 (44%) | |||
AG | 14 (39%) | not tested | ||
GG | 6 (17%) | |||
MAF | 0.36 | |||
CYP2B6 499C>G (rs3826711) ‡ | ||||
CC | 36 (100%) | not tested | ||
CYP2B6*29 ‡ | ||||
*1 /*1 | 36 (100%) | not tested |
Data are median (range) or no. (%) of subjects.
51 children in the CHAPAS‐3 study who underwent both intensive and sparse sampling are counted in both categories.
Baseline values.
162 pts from both CHAPAS‐3 and ARROW studies.
36 pts from ARROW study. HWE, Hardy–Weinberg equilibrium; iPK, intensive sampling; MAF, minor allele frequency; sPK, sparse sampling.